I'm very excited to announce that we've raised a $21.8M oversubscribed Series A!
+ a sneak peak into the absurd story of how Synex started ๐
https://t.co/BMsHDqNZru
Every wearable company is racing to add blood testing.
Oura, WHOOP, Levels, and Ultrahuman are all partnering with Quest or Labcorp to layer diagnostics into their apps.
Apple's building an "AI doctor" for Health app.
Proactive health management is the new moat.
We're looking for a world-class signal processing / ML engineer!
If you dream in latent spaces and want to work with the most talented, brilliant group of people I've ever met conquering the Holy Grail of health monitoring, please consider joining us๐
https://t.co/ZwdemqC1hr
@TheSulkyFireman Ultra miniaturized MRI that you can hold in your hand
We measure magnetic resonance signals from blood non-invasively in your fingertip, capable of directly measuring dozens of different metabolites
Learn more here: https://t.co/0zFeK0w0sn
Synex is building a platform to measure your health non-invasively, everything from glucose to cholesterol
Your metabolism on one device: no needles, no finger pricks
We want your feedback on what resonates most with you!
Polls below ๐
There is substance to this for single targets, but combinations have far more promise for radical extension IMO. Rapa + acarbose paper being a prime example.
Consider a cocktail of 5+ interventions targeting independent mechanisms. Lots of potential, but much harder to test all the permutations
Very excited to share that our latest clinical study has received ethics board approval and we are actively recruiting!
Synex is developing a non-invasive glucose monitor that delivers the same accuracy as traditional devices, without the pain of needles.
If you or a loved one has diabetes and are in the Toronto area, you may qualify for our study and help us shape the future of healthcare!
Register at: [email protected]
Or call: 1-888-562-4554
Learn more at https://t.co/RwiRcqgM68
Very excited to share that our latest clinical study has received ethics board approval and we are actively recruiting!
Synex is developing a non-invasive glucose monitor that delivers the same accuracy as traditional devices, without the pain of needles.
If you or a loved one has diabetes and are in the Toronto area, you may qualify for our study and help us shape the future of healthcare!
Register at: [email protected]
Or call: 1-888-562-4554
Learn more at https://t.co/RwiRcqgM68
We're in a unique position to improve the lives of millions of people
If you align with our vision of predictive health, please consider joining us - we're hiring!
https://t.co/0zFeK0vsCP
The reason you hate medical devices is because you are not the customer
Insurers are
No incentive to build a beautiful user experience when the user is not the payer
This is absolutely backwards
At Synex, our core belief is to start with our users and work backwards
Healthcare should be enjoyable, not a pain in the ass
With a 100x better user experience, we expect much more engagement for improved health outcomes and a device that feels like magic to use
These types of downstream benefits are expected from a true geroprotective drug
My guess is GLP-1s primarily act through caloric restriction, but if thereโs other mechanisms thatโs even more exciting
Are there any labs running large scale GLP-1 lifespan studies on mice??
In addition to potential benefits for Parkinson's, a new meta-analysis of randomized controlled trials of GLP-1 drugs found that they halved the risk of dementia.
Rates of old-age cognitive impairment might plummet in the near future.